Learn about the latest advances in inflammatory bowel disease (IBD) and advanced endoscopic procedures from the experts of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai. Ever since Burrill Crohn, MD, and colleagues described the condition now known as Crohn’s disease, Mount Sinai gastroenterologists have been on the cutting edge of diagnosing and treating IBD. Our Susan and Leonard Feinstein IBD Clinical Center, led by Jean-Frederic Colombel, MD, and Marla Dubinsky, MD, is at the forefront of research into the causes of IBD and leads the field in clinical trials that have changed the way patients are cared for. Additionally, at our Center for Advanced Colonoscopy and Therapeutic Endoscopy at Sinai (CACTES), led by Christopher DiMaio, MD, our physicians are pioneering new tools and techniques to identify, diagnose, and treat the most complex digestive disorders.
Latest Videos| View More >
Video
The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center
See what makes our Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center unique.
Video
Looking Back and in the Distance: Are We on Track to Change IBD Patients' Lives
Helping patients with IBD
Video
COVID-19: IBD Update From the Front Lines
A new database tracks risk factors for IBD patients who have COVID-19
Video
Understanding the Human Microbiome and its Therapeutic Potential
Understanding IBD and the microbiome
Video
Severe Acute and Necrotizing Pancreatitis: Paradigm Shifts in Management
Helping patients with pancreatitis
Video
Breaking Down the Barriers: Disparities in Colorectal Cancer Screening in African Americans
African Americans experience low rates of colorectal cancer screening
Video
Recent Advances in the Diagnosis and Management of Barrett's Esophagus
Advances in Barrett's Esophagus
Video
Colon Cancer Screening: From Molecular Genetics to Health Equity
Colon cancer screening: what to look for
Video
COVID-19: Implications on Inflammatory Bowel Disease
COVID-19: Implications on Inflammatory Bowel Disease
Featured Content
Document
Vedolizumab Versus Adalimumab for Moderate to Severe Ulcerative Colitis
In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures.
Document
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Ustekinumab is more effective than placebo as an induction and maintenance therapy for UC.
Document
New research in the disruptions in the GI tract of HIV-1 patients
Document
Population analysis on IBD in Western Countries
Document
Study of infants born to mothers with IBD
